Practicing physicians in the United States can now purchase BELOTERO BALANCE (www.belotero.com)—the latest HA filler to receive FDA approval. BELOTERO BALANCE was approved by the Food and Drug Administration (www.fda.gov) in November 2011 as a safe solution for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds and perioral lines. This dermal filler joins Merz Aesthetics' existing portfolio of injectable products, including RADIESSE Volumizing Filler and Asclera (polidocanol) Injection.
“We believe that BELOTERO BALANCE has a unique place in the aesthetic market as a competitive and effective choice that provides physicians with a new option for ensuring meaningful results for patients seeking to treat the appearance of both wrinkles and folds,” said Dennis Condon, president of Merz Aesthetics. “We look forward to the availability of BELOTERO BALANCE as we continue our company's legacy of providing the field of aesthetic dermatology with unparalleled service and a wide range of safe and effective products.”